Nordic BioSite Group announces acquisition of LubioScience & name change to Europa Biosite

Established in 1997, Nordic BioSite was founded with the ambition to be the leading Nordic distribution partner of premium reagents for life science research use. Four years ago, following the successful penetration of the Nordic market, their commercial ambition was broadened to become the leading life science distributor in Europe. Nordic BioSite Group has since increased sales x5 through high organic growth and yearly best-in class acquisitions.

Today we are delighted to announce our latest acquisition, LubioScience, in Switzerland. As the fastest growing life science distributor in Switzerland, LubioScience is an excellent addition to our Group and an important step towards our ambition to provide exceptional distribution services across Europe.

In recognition of our geographical expansion, we are ready to progress to a new name that is more reflective of our growth and future ambitions. Effective from today, Nordic BioSite Group will be known as Europa Biosite. Europa Biosite is a name that reflects our aspirations to be the leading site for life science products within Europe. Looking to the future, we aspire to further develop our success across Europe through additional industry-leading acquisitions and continued high organic growth. New website to be launched October 2023.

“Switzerland is a key research hub in Europe and hence we have been eager to be present there to help existing and new suppliers gain access to this fast-growing market. LubioScience has been #1 on our target list for a long time as we have been impressed with the success they have had in the Swiss market. I am sure there are many things we can learn from their success to replicate within the Group, just like we can transfer our commercial and operational best practices to LubioScience” says CEO Sune Schmolker. Dr. Tobias Dietschy and Dr. Daniel Auerbach will continue working at LubioScience, and comment in a shared statement on the deal: “The consolidation of the European life science distribution market will generate value for suppliers and customers, and we see an exciting future for LubioScience as part of the fastest growing pan-European group of distributors within our industry”.

The parties have chosen not to disclose the financial terms of the transaction.

For further information:

Europa Biosite: Sune Schmolker, CEO, sune.schmolker@nordicbiosite.com, +45 42 92 17 79

LubioScience: Tobias Dietschy, tobias.dietschy@lubio.ch, + 41 76 559 45 67

About LubioScience

LubioScience has been a leading distributor of life science products for over 20 years in its home market, Switzerland. Its highly qualified employees support local customers in gaining access to innovative products from top quality global life science manufacturers. For further information please visit www.lubio.ch

About Europa Biosite

Europa Biosite is a European supplier of life science products and services. We are a group of five leading distribution companies: Biomol in Germany, Cambridge Bioscience in the UK and Ireland, Nordic BioSite in the Nordics and Baltics, Sanbio in Benelux and Szabo-Scandic in Austria. The group has a portfolio of over 5 million products, representation in 15 European countries and a highly skilled team of over 130 employees.